Personalized immunotherapy in cancer precision medicine
With the significant advances in cancer genomics using next-generation sequencing technologies, genomic and molecular profiling-based precision medicine is used as a part of routine clinical test for guiding and selecting the most appropriate treatments for individual cancer patients. Although many...
Guardado en:
Autores principales: | Kazuma Kiyotani, Yujiro Toyoshima, Yusuke Nakamura |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
China Anti-Cancer Association
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2d8dff79209e45a3b7ae968557deba2c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment
por: Jagmohan Singh, et al.
Publicado: (2021) -
Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?
por: Li-Feng Hu, et al.
Publicado: (2021) -
Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1
por: Changbo Sun, et al.
Publicado: (2021) -
Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy
por: Lin X, et al.
Publicado: (2021) -
A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma
por: Alexandre Harari, et al.
Publicado: (2021)